 | • レポートコード：MRC2-11QY06532 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はフリードライヒ運動失調症治療薬のグローバル市場について調査・分析したレポートです。種類別（ADVM-063、AGIL-FA、BHV-4157、BVA-202、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別フリードライヒ運動失調症治療薬の競争状況、市場シェア ・世界のフリードライヒ運動失調症治療薬市場：種類別市場規模 2015年-2020年（ADVM-063、AGIL-FA、BHV-4157、BVA-202、その他） ・世界のフリードライヒ運動失調症治療薬市場：種類別市場規模予測 2021年-2026年（ADVM-063、AGIL-FA、BHV-4157、BVA-202、その他） ・世界のフリードライヒ運動失調症治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のフリードライヒ運動失調症治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のフリードライヒ運動失調症治療薬市場分析：米国、カナダ ・ヨーロッパのフリードライヒ運動失調症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのフリードライヒ運動失調症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のフリードライヒ運動失調症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのフリードライヒ運動失調症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adverum Biotechnologies Inc、BioMarin Pharmaceutical Inc.、Biovista Inc.、Cardero Therapeutics Inc、Catabasis Pharmaceuticals, Inc.、Forward Pharma A/S、Ixchel Pharma LLC、Pfizer Inc、ProQR Therapeutics NV、RaNA Therapeutics Inc、Reata Pharmaceuticals Inc、Retrotope Inc、Takeda、STATegics Inc、Voyager Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Friedreich Ataxia Drug Market
The global Friedreich Ataxia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Friedreich Ataxia Drug Scope and Market Size
Friedreich Ataxia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Friedreich Ataxia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Friedreich Ataxia Drug market is segmented into
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Segment by Application, the Friedreich Ataxia Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Friedreich Ataxia Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Friedreich Ataxia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Friedreich Ataxia Drug Market Share Analysis
Friedreich Ataxia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Friedreich Ataxia Drug business, the date to enter into the Friedreich Ataxia Drug market, Friedreich Ataxia Drug product introduction, recent developments, etc.
The major vendors covered:
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Takeda
STATegics Inc
Voyager Therapeutics Inc
1 Study Coverage
1.1 Friedreich Ataxia Drug Product Introduction
1.2 Market Segments
1.3 Key Friedreich Ataxia Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Type
1.4.2 ADVM-063
1.4.3 AGIL-FA
1.4.4 BHV-4157
1.4.5 BVA-202
1.4.6 Others
1.5 Market by Application
1.5.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Friedreich Ataxia Drug Market Size, Estimates and Forecasts
2.1.1 Global Friedreich Ataxia Drug Revenue 2015-2026
2.1.2 Global Friedreich Ataxia Drug Sales 2015-2026
2.2 Global Friedreich Ataxia Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Friedreich Ataxia Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Friedreich Ataxia Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Friedreich Ataxia Drug Competitor Landscape by Players
3.1 Friedreich Ataxia Drug Sales by Manufacturers
3.1.1 Friedreich Ataxia Drug Sales by Manufacturers (2015-2020)
3.1.2 Friedreich Ataxia Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Friedreich Ataxia Drug Revenue by Manufacturers
3.2.1 Friedreich Ataxia Drug Revenue by Manufacturers (2015-2020)
3.2.2 Friedreich Ataxia Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Friedreich Ataxia Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Friedreich Ataxia Drug Revenue in 2019
3.2.5 Global Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Friedreich Ataxia Drug Price by Manufacturers
3.4 Friedreich Ataxia Drug Manufacturing Base Distribution, Product Types
3.4.1 Friedreich Ataxia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Friedreich Ataxia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Friedreich Ataxia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Friedreich Ataxia Drug Market Size by Type (2015-2020)
4.1.1 Global Friedreich Ataxia Drug Sales by Type (2015-2020)
4.1.2 Global Friedreich Ataxia Drug Revenue by Type (2015-2020)
4.1.3 Friedreich Ataxia Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Friedreich Ataxia Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Friedreich Ataxia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Friedreich Ataxia Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Friedreich Ataxia Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Friedreich Ataxia Drug Market Size by Application (2015-2020)
5.1.1 Global Friedreich Ataxia Drug Sales by Application (2015-2020)
5.1.2 Global Friedreich Ataxia Drug Revenue by Application (2015-2020)
5.1.3 Friedreich Ataxia Drug Price by Application (2015-2020)
5.2 Friedreich Ataxia Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Friedreich Ataxia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Friedreich Ataxia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Friedreich Ataxia Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Friedreich Ataxia Drug by Country
6.1.1 North America Friedreich Ataxia Drug Sales by Country
6.1.2 North America Friedreich Ataxia Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Friedreich Ataxia Drug Market Facts & Figures by Type
6.3 North America Friedreich Ataxia Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Friedreich Ataxia Drug by Country
7.1.1 Europe Friedreich Ataxia Drug Sales by Country
7.1.2 Europe Friedreich Ataxia Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Friedreich Ataxia Drug Market Facts & Figures by Type
7.3 Europe Friedreich Ataxia Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Friedreich Ataxia Drug by Region
8.1.1 Asia Pacific Friedreich Ataxia Drug Sales by Region
8.1.2 Asia Pacific Friedreich Ataxia Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Type
8.3 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Friedreich Ataxia Drug by Country
9.1.1 Latin America Friedreich Ataxia Drug Sales by Country
9.1.2 Latin America Friedreich Ataxia Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Friedreich Ataxia Drug Market Facts & Figures by Type
9.3 Central & South America Friedreich Ataxia Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Friedreich Ataxia Drug by Country
10.1.1 Middle East and Africa Friedreich Ataxia Drug Sales by Country
10.1.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Type
10.3 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Adverum Biotechnologies Inc
11.1.1 Adverum Biotechnologies Inc Corporation Information
11.1.2 Adverum Biotechnologies Inc Description and Business Overview
11.1.3 Adverum Biotechnologies Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products Offered
11.1.5 Adverum Biotechnologies Inc Related Developments
11.2 BioMarin Pharmaceutical Inc.
11.2.1 BioMarin Pharmaceutical Inc. Corporation Information
11.2.2 BioMarin Pharmaceutical Inc. Description and Business Overview
11.2.3 BioMarin Pharmaceutical Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Products Offered
11.2.5 BioMarin Pharmaceutical Inc. Related Developments
11.3 Biovista Inc.
11.3.1 Biovista Inc. Corporation Information
11.3.2 Biovista Inc. Description and Business Overview
11.3.3 Biovista Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biovista Inc. Friedreich Ataxia Drug Products Offered
11.3.5 Biovista Inc. Related Developments
11.4 Cardero Therapeutics Inc
11.4.1 Cardero Therapeutics Inc Corporation Information
11.4.2 Cardero Therapeutics Inc Description and Business Overview
11.4.3 Cardero Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Products Offered
11.4.5 Cardero Therapeutics Inc Related Developments
11.5 Catabasis Pharmaceuticals, Inc.
11.5.1 Catabasis Pharmaceuticals, Inc. Corporation Information
11.5.2 Catabasis Pharmaceuticals, Inc. Description and Business Overview
11.5.3 Catabasis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Products Offered
11.5.5 Catabasis Pharmaceuticals, Inc. Related Developments
11.6 Forward Pharma A/S
11.6.1 Forward Pharma A/S Corporation Information
11.6.2 Forward Pharma A/S Description and Business Overview
11.6.3 Forward Pharma A/S Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Forward Pharma A/S Friedreich Ataxia Drug Products Offered
11.6.5 Forward Pharma A/S Related Developments
11.7 Ixchel Pharma LLC
11.7.1 Ixchel Pharma LLC Corporation Information
11.7.2 Ixchel Pharma LLC Description and Business Overview
11.7.3 Ixchel Pharma LLC Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Products Offered
11.7.5 Ixchel Pharma LLC Related Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Corporation Information
11.8.2 Pfizer Inc Description and Business Overview
11.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Inc Friedreich Ataxia Drug Products Offered
11.8.5 Pfizer Inc Related Developments
11.9 ProQR Therapeutics NV
11.9.1 ProQR Therapeutics NV Corporation Information
11.9.2 ProQR Therapeutics NV Description and Business Overview
11.9.3 ProQR Therapeutics NV Sales, Revenue and Gross Margin (2015-2020)
11.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Products Offered
11.9.5 ProQR Therapeutics NV Related Developments
11.10 RaNA Therapeutics Inc
11.10.1 RaNA Therapeutics Inc Corporation Information
11.10.2 RaNA Therapeutics Inc Description and Business Overview
11.10.3 RaNA Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Products Offered
11.10.5 RaNA Therapeutics Inc Related Developments
11.1 Adverum Biotechnologies Inc
11.1.1 Adverum Biotechnologies Inc Corporation Information
11.1.2 Adverum Biotechnologies Inc Description and Business Overview
11.1.3 Adverum Biotechnologies Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Products Offered
11.1.5 Adverum Biotechnologies Inc Related Developments
11.12 Retrotope Inc
11.12.1 Retrotope Inc Corporation Information
11.12.2 Retrotope Inc Description and Business Overview
11.12.3 Retrotope Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Retrotope Inc Products Offered
11.12.5 Retrotope Inc Related Developments
11.13 Takeda
11.13.1 Takeda Corporation Information
11.13.2 Takeda Description and Business Overview
11.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Takeda Products Offered
11.13.5 Takeda Related Developments
11.14 STATegics Inc
11.14.1 STATegics Inc Corporation Information
11.14.2 STATegics Inc Description and Business Overview
11.14.3 STATegics Inc Sales, Revenue and Gross Margin (2015-2020)
11.14.4 STATegics Inc Products Offered
11.14.5 STATegics Inc Related Developments
11.15 Voyager Therapeutics Inc
11.15.1 Voyager Therapeutics Inc Corporation Information
11.15.2 Voyager Therapeutics Inc Description and Business Overview
11.15.3 Voyager Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Voyager Therapeutics Inc Products Offered
11.15.5 Voyager Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Friedreich Ataxia Drug Market Estimates and Projections by Region
12.1.1 Global Friedreich Ataxia Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Friedreich Ataxia Drug Revenue Forecast by Regions 2021-2026
12.2 North America Friedreich Ataxia Drug Market Size Forecast (2021-2026)
12.2.1 North America: Friedreich Ataxia Drug Sales Forecast (2021-2026)
12.2.2 North America: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
12.2.3 North America: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Friedreich Ataxia Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Friedreich Ataxia Drug Sales Forecast (2021-2026)
12.3.2 Europe: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Friedreich Ataxia Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Friedreich Ataxia Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Friedreich Ataxia Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Friedreich Ataxia Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Friedreich Ataxia Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Friedreich Ataxia Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Friedreich Ataxia Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Friedreich Ataxia Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Friedreich Ataxia Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Friedreich Ataxia Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Friedreich Ataxia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Friedreich Ataxia Drug Market Segments
Table 2. Ranking of Global Top Friedreich Ataxia Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Friedreich Ataxia Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ADVM-063
Table 5. Major Manufacturers of AGIL-FA
Table 6. Major Manufacturers of BHV-4157
Table 7. Major Manufacturers of BVA-202
Table 8. Major Manufacturers of Others
Table 9. Global Friedreich Ataxia Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Friedreich Ataxia Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Friedreich Ataxia Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Friedreich Ataxia Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Friedreich Ataxia Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Friedreich Ataxia Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Friedreich Ataxia Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Friedreich Ataxia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Friedreich Ataxia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Friedreich Ataxia Drug as of 2019)
Table 18. Friedreich Ataxia Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Friedreich Ataxia Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Friedreich Ataxia Drug Price (2015-2020) (USD/Pcs)
Table 21. Friedreich Ataxia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Friedreich Ataxia Drug Product Type
Table 23. Date of International Manufacturers Enter into Friedreich Ataxia Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Friedreich Ataxia Drug Sales Share by Type (2015-2020)
Table 27. Global Friedreich Ataxia Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Friedreich Ataxia Drug Revenue Share by Type (2015-2020)
Table 29. Friedreich Ataxia Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Friedreich Ataxia Drug Sales Share by Application (2015-2020)
Table 32. North America Friedreich Ataxia Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Friedreich Ataxia Drug Sales Market Share by Country (2015-2020)
Table 34. North America Friedreich Ataxia Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Friedreich Ataxia Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Table 38. North America Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Friedreich Ataxia Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Friedreich Ataxia Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Friedreich Ataxia Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Friedreich Ataxia Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Friedreich Ataxia Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Friedreich Ataxia Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Friedreich Ataxia Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Friedreich Ataxia Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Friedreich Ataxia Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Table 72. Adverum Biotechnologies Inc Corporation Information
Table 73. Adverum Biotechnologies Inc Description and Major Businesses
Table 74. Adverum Biotechnologies Inc Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Adverum Biotechnologies Inc Product
Table 76. Adverum Biotechnologies Inc Recent Development
Table 77. BioMarin Pharmaceutical Inc. Corporation Information
Table 78. BioMarin Pharmaceutical Inc. Description and Major Businesses
Table 79. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. BioMarin Pharmaceutical Inc. Product
Table 81. BioMarin Pharmaceutical Inc. Recent Development
Table 82. Biovista Inc. Corporation Information
Table 83. Biovista Inc. Description and Major Businesses
Table 84. Biovista Inc. Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Biovista Inc. Product
Table 86. Biovista Inc. Recent Development
Table 87. Cardero Therapeutics Inc Corporation Information
Table 88. Cardero Therapeutics Inc Description and Major Businesses
Table 89. Cardero Therapeutics Inc Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Cardero Therapeutics Inc Product
Table 91. Cardero Therapeutics Inc Recent Development
Table 92. Catabasis Pharmaceuticals, Inc. Corporation Information
Table 93. Catabasis Pharmaceuticals, Inc. Description and Major Businesses
Table 94. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Catabasis Pharmaceuticals, Inc. Product
Table 96. Catabasis Pharmaceuticals, Inc. Recent Development
Table 97. Forward Pharma A/S Corporation Information
Table 98. Forward Pharma A/S Description and Major Businesses
Table 99. Forward Pharma A/S Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Forward Pharma A/S Product
Table 101. Forward Pharma A/S Recent Development
Table 102. Ixchel Pharma LLC Corporation Information
Table 103. Ixchel Pharma LLC Description and Major Businesses
Table 104. Ixchel Pharma LLC Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Ixchel Pharma LLC Product
Table 106. Ixchel Pharma LLC Recent Development
Table 107. Pfizer Inc Corporation Information
Table 108. Pfizer Inc Description and Major Businesses
Table 109. Pfizer Inc Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Pfizer Inc Product
Table 111. Pfizer Inc Recent Development
Table 112. ProQR Therapeutics NV Corporation Information
Table 113. ProQR Therapeutics NV Description and Major Businesses
Table 114. ProQR Therapeutics NV Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. ProQR Therapeutics NV Product
Table 116. ProQR Therapeutics NV Recent Development
Table 117. RaNA Therapeutics Inc Corporation Information
Table 118. RaNA Therapeutics Inc Description and Major Businesses
Table 119. RaNA Therapeutics Inc Friedreich Ataxia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. RaNA Therapeutics Inc Product
Table 121. RaNA Therapeutics Inc Recent Development
Table 122. Reata Pharmaceuticals Inc Corporation Information
Table 123. Reata Pharmaceuticals Inc Description and Major Businesses
Table 124. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Reata Pharmaceuticals Inc Product
Table 126. Reata Pharmaceuticals Inc Recent Development
Table 127. Retrotope Inc Corporation Information
Table 128. Retrotope Inc Description and Major Businesses
Table 129. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Retrotope Inc Product
Table 131. Retrotope Inc Recent Development
Table 132. Takeda Corporation Information
Table 133. Takeda Description and Major Businesses
Table 134. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Takeda Product
Table 136. Takeda Recent Development
Table 137. STATegics Inc Corporation Information
Table 138. STATegics Inc Description and Major Businesses
Table 139. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. STATegics Inc Product
Table 141. STATegics Inc Recent Development
Table 142. Voyager Therapeutics Inc Corporation Information
Table 143. Voyager Therapeutics Inc Description and Major Businesses
Table 144. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Voyager Therapeutics Inc Product
Table 146. Voyager Therapeutics Inc Recent Development
Table 147. Global Friedreich Ataxia Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 148. Global Friedreich Ataxia Drug Sales Market Share Forecast by Regions (2021-2026)
Table 149. Global Friedreich Ataxia Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 150. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 151. North America: Friedreich Ataxia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. North America: Friedreich Ataxia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Europe: Friedreich Ataxia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 154. Europe: Friedreich Ataxia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Asia Pacific: Friedreich Ataxia Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 156. Asia Pacific: Friedreich Ataxia Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 157. Latin America: Friedreich Ataxia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 158. Latin America: Friedreich Ataxia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Middle East and Africa: Friedreich Ataxia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 160. Middle East and Africa: Friedreich Ataxia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 162. Key Challenges
Table 163. Market Risks
Table 164. Main Points Interviewed from Key Friedreich Ataxia Drug Players
Table 165. Friedreich Ataxia Drug Customers List
Table 166. Friedreich Ataxia Drug Distributors List
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Friedreich Ataxia Drug Product Picture
Figure 2. Global Friedreich Ataxia Drug Sales Market Share by Type in 2020 & 2026
Figure 3. ADVM-063 Product Picture
Figure 4. AGIL-FA Product Picture
Figure 5. BHV-4157 Product Picture
Figure 6. BVA-202 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Friedreich Ataxia Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Friedreich Ataxia Drug Report Years Considered
Figure 13. Global Friedreich Ataxia Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Friedreich Ataxia Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Friedreich Ataxia Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Friedreich Ataxia Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Friedreich Ataxia Drug Sales Market Share by Region in 2019
Figure 18. Global Friedreich Ataxia Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Friedreich Ataxia Drug Revenue Market Share by Region in 2019
Figure 20. Global Friedreich Ataxia Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Friedreich Ataxia Drug Revenue in 2019
Figure 22. Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Friedreich Ataxia Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Friedreich Ataxia Drug Sales Market Share by Type in 2019
Figure 25. Global Friedreich Ataxia Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Friedreich Ataxia Drug Revenue Market Share by Type in 2019
Figure 27. Global Friedreich Ataxia Drug Market Share by Price Range (2015-2020)
Figure 28. Global Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Friedreich Ataxia Drug Sales Market Share by Application in 2019
Figure 30. Global Friedreich Ataxia Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Friedreich Ataxia Drug Revenue Market Share by Application in 2019
Figure 32. North America Friedreich Ataxia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Friedreich Ataxia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Friedreich Ataxia Drug Sales Market Share by Country in 2019
Figure 35. North America Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Friedreich Ataxia Drug Market Share by Type in 2019
Figure 41. North America Friedreich Ataxia Drug Market Share by Application in 2019
Figure 42. Europe Friedreich Ataxia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Friedreich Ataxia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Friedreich Ataxia Drug Sales Market Share by Country in 2019
Figure 45. Europe Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 46. Germany Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Friedreich Ataxia Drug Market Share by Type in 2019
Figure 57. Europe Friedreich Ataxia Drug Market Share by Application in 2019
Figure 58. Asia Pacific Friedreich Ataxia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Friedreich Ataxia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Region in 2019
Figure 62. China Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Friedreich Ataxia Drug Market Share by Type in 2019
Figure 85. Asia Pacific Friedreich Ataxia Drug Market Share by Application in 2019
Figure 86. Latin America Friedreich Ataxia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Friedreich Ataxia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Friedreich Ataxia Drug Sales Market Share by Country in 2019
Figure 89. Latin America Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Friedreich Ataxia Drug Market Share by Type in 2019
Figure 97. Latin America Friedreich Ataxia Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Friedreich Ataxia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Friedreich Ataxia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Friedreich Ataxia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Friedreich Ataxia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Friedreich Ataxia Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Friedreich Ataxia Drug Market Share by Application in 2019
Figure 110. North America Friedreich Ataxia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Friedreich Ataxia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Friedreich Ataxia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Friedreich Ataxia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Friedreich Ataxia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Friedreich Ataxia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Friedreich Ataxia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Friedreich Ataxia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Friedreich Ataxia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Friedreich Ataxia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 薬物スクリーニング検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Drug Screening Laboratory Service Market The global Drug Screening Laboratory Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 子宮内膜ポリープ治療薬の世界市場（～2026年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …